SCHEMBL6537899

SCHEMBL6537899

CS(=O)(=O)c1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.46
MAPT P10636 4/20 0.45
TP53 P04637 1/20 0.45
PLEC Q15149 1/20 0.44
HTT P42858 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
GAA P10253 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ABL1 P00519 1/20 0.43
SRC P12931 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
KIF18A Q8NI77 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537382 0.83 SLC40A1 (0.52) KDRMAPTTP53PLECHTT
SCHEMBL6537713 0.82 JAK2 (0.52) KDRMAPTTP53PLECHTT
SCHEMBL6537399 0.81 KDR (0.49) KDRMAPTTP53PLECHTT
SCHEMBL6537743 0.81 KDR (0.48) KDRMAPTTP53PLECHTT
SCHEMBL6537536 0.81 KDR (0.52) KDRMAPTTP53PLECHTT
SCHEMBL6537952 0.81 KDR (0.46) KDRMAPTTP53PLECHTT
SCHEMBL6538256 0.80 MAPT (0.52) KDRMAPTTP53PLECHTT
SCHEMBL6537670 0.79 MAPT (0.47) KDRMAPTTP53PLECHTT
SCHEMBL6537883 0.79 KDR (0.46) KDRMAPTTP53PLECHTT
SCHEMBL6537425 0.79 KDR (0.51) KDRMAPTTP53PLECHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed